Fast-Tracking Psychedelics Research – YouTube
Accelerated psychedelics research pathways could significantly impact treatment-resistant psychiatric conditions. This emerging focus highlights the potential for new therapeutic options. Understanding these pathways is crucial for clinicians and…
Huge Study Finds No Evidence Cannabis Helps Anxiety, Depression, or PTSD – PTTC Network
A recent large study on cannabis efficacy mental health conditions found no evidence supporting its benefits for anxiety, depression, or PTSD. This challenges common perceptions and underscores the need for more rigorous research. Clinicians should…
Smoking Weed as a Teen Might Change Your Life for the Worse — UC San Diego Study
Adolescent cannabis exposure brain development is a critical area of study due to its potential long-term effects. The UC San Diego research highlights risks associated with cannabis use during teen years. Understanding these risks informs clinical…
A Health Department-commissioned Study Shows Growing Reliance on Cannabis
The health department cannabis study reveals a growing reliance on cannabis for psychiatric conditions. However, limited methodology details restrict clinical analysis. Clinicians await full study data to assess its relevance.
Talking to Teens About Cannabis: Harm Reduction and Clinical Guidance
Adolescent cannabis use harm reduction is critical as legalization expands and exposure patterns shift. Clinicians must understand current evidence on developmental risks to guide teens effectively. Harm reduction approaches focus on delaying use and…
Major Study Links Teen Cannabis Use to Delayed Thinking and Memory Skills
This major study highlights teen cannabis delayed memory effects on adolescent cognitive function. The research shows significant associations between cannabis use and delayed thinking skills. These findings provide critical insights for clinicians…
Trump Signs Order to Fast-Track Psychedelic Research | Euronews – CED Clinic
The focus on psychedelic research acceleration aims to speed up evidence generation for psychiatric conditions. This policy shift may influence FDA approval timelines and clinical trial accessibility. It highlights emerging developments in psychedelic…
Trump Signs Order to Accelerate Psychedelic Drug Research
The focus on psychedelic drug research acceleration is reshaping clinical trial timelines and regulatory pathways. This policy change aims to speed up access to evidence-based psychedelic therapies. Safety protocols and clinical standards remain…
Cannabis and Mental Health: Why the Evidence Looks So Contradictory—and What Actually Matters
Clinicians often face cannabis mental health contradictions in research findings. These contradictions arise from varying THC and CBD effects and individual patient factors. Understanding these contradictions is key for evidence-based clinical decisions.
President Trump Signs Executive Order Encouraging Psychedelic Research
The psychedelic executive order research marks a significant shift in federal policy encouraging clinical trials on psychedelic drugs. This change aims to reduce regulatory barriers and accelerate research on treatment-resistant psychiatric conditions.…